28Jun
[Audio] Episode 148 -- A Review of the Novartis and Alcon FCPA Enforcement Action
Even during this difficult time of the pandemic, economic uncertainty and social unrest, the Justice Department and the SEC have concluded a major FCPA enforcement action. Novartis and Alcon (which was a Novartis subsidiary at the time of the misconduct) agreed to pay a total of $345 million in criminal and civil penalties. Novartis spun off Alcon in 2019. Under the DOJ settlement, Novartis and Alcon each entered into a deferred prosecution agreement; Novartis agreed to pay a fine of $225...
By:
Michael Volkov
Source Url: https://www.jdsupra.com/legalnews/episode-148-a-review-of-the-novartis-40216/
Related
When it comes to effective internal whistleblower hotlines, silence is never a sign of success. It i...
Read More >
The Department of Homeland Security (DHS) recently announced a pilot project to collect DNA samples ...
Read More >
It is well established that welfare plans are not subject to the vesting requirements of ERISA. Ther...
Read More >
Business Law Today previously posted this piece discussing key Delaware General Corporate Law differ...
Read More >
As colleges and universities across the country deal with the challenges of remote learning and try ...
Read More >
A federal court in Alabama held that an employer’s request to count an employee’s prescription med...
Read More >